Top compounds associated with response to ZNF230


Feature Type Standardized
Nominal ANOVA
mRNA BX-912 GDSC1000 pan-cancer AAC 0.19 7e-11
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.2 4e-10
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.23 4e-10
mRNA barasertib CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA XL-184 GDSC1000 pan-cancer AAC 0.18 1e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.15 5e-07
mRNA ML311 CTRPv2 pan-cancer AAC 0.16 1e-06
Download CSV